Sonire Therapeutics Inc
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 2020-02-01
- Employees
- 11
- Market Cap
- -
A Study of Suizenji in Patients With Unresectable Pancreatic Cancer
Not Applicable
Recruiting
- Conditions
- Unresectable Pancreatic Cancer
- Interventions
- Drug: Nal-IRI/FLDevice: SuizenjiDrug: mFOLFIRINOXDrug: Gem/nab-PTX
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- SONIRE Therapeutics Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT05601323
- Locations
- 🇯🇵
Aichi Medical University Hospital, Nagakute-shi, Aichi, Japan
🇯🇵Tohoku University Hospital, Sendai-shi, Miyagi, Japan
🇯🇵Tokyo Medical University Hospita, Shinjuku-ku, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath